Lakefront Biotherapeutics (LKFT) Asset Writedowns and Impairment (2016 - 2022)
Lakefront Biotherapeutics (LKFT) posted quarterly Asset Writedowns and Impairment of $1.3 million for Q1 2022, up 1555.71% on a QoQ basis from $79656.8 in Q1 2020.
Lakefront Biotherapeutics (LKFT) Asset Writedowns and Impairment (2016 - 2022) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Asset Writedowns and Impairment for 4 consecutive years, with $1.3 million the latest figure, recorded in Q1 2022.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $1.3 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $24.9 million (changed N/A YoY) and the FY2025 annual result came in at $1.9 million, changed N/A from the prior year.
- Asset Writedowns and Impairment climbed to $1.3 million in Q1 2022 per LKFT's latest filing, from $79656.8 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for LKFT reached as high as $1.3 million in Q1 2022 and fell as low as $79656.8 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 1.32 Mn |
| Mar 31, 2022 | 1.32 Mn |
| Mar 31, 2020 | 79,656.80 |
| Mar 31, 2020 | 79,656.80 |
| Jun 30, 2017 | 20.02 Mn |
| Jun 30, 2017 | 20.02 Mn |
| Mar 31, 2017 | 3.43 Mn |
| Mar 31, 2017 | 3.43 Mn |
| Jun 30, 2016 | -4.63 Mn |
| Jun 30, 2016 | -4.63 Mn |
| Mar 31, 2016 | 5.97 Mn |
| Mar 31, 2016 | 5.97 Mn |